107 related articles for article (PubMed ID: 3930419)
1. Histopathologic analysis of intraocular allogeneic tumors in mice.
Luckenbach MW; Streilein JW; Niederkorn JY
Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1368-76. PubMed ID: 3930419
[TBL] [Abstract][Full Text] [Related]
2. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous immune rejection of intraocular tumors in mice.
Niederkorn JY; Meunier PC
Invest Ophthalmol Vis Sci; 1985 Jun; 26(6):877-84. PubMed ID: 3924853
[TBL] [Abstract][Full Text] [Related]
4. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
5. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice.
Niederkorn J; Streilein JW; Shadduck JA
Invest Ophthalmol Vis Sci; 1981 Mar; 20(3):355-63. PubMed ID: 6782034
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of immunity to intraocular tumors in mice.
Niederkorn JY; Streilein JW
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):336-42. PubMed ID: 6421767
[TBL] [Abstract][Full Text] [Related]
7. Intracamerally induced concomitant immunity: mice harboring progressively growing intraocular tumors are immune to spontaneous metastases and secondary tumor challenge.
Niederkorn JY; Streilein JW
J Immunol; 1983 Nov; 131(5):2587-94. PubMed ID: 6415174
[TBL] [Abstract][Full Text] [Related]
8. Induction of anterior chamber-associated immune deviation (ACAID) by allogeneic intraocular tumors does not require splenic metastases.
Niederkorn JY; Streilein JW
J Immunol; 1982 Jun; 128(6):2470-4. PubMed ID: 6804562
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cytotoxic T cell responses to intracameral allogeneic tumors.
Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Feb; 30(2):323-9. PubMed ID: 2492486
[TBL] [Abstract][Full Text] [Related]
10. Requirement of CD80+ costimulation for rejection of ocular tumors and termination of immune privilege.
Chen PW; Uno T; Ksander BR
Exp Eye Res; 2006 Sep; 83(3):574-83. PubMed ID: 16643898
[TBL] [Abstract][Full Text] [Related]
11. Immune rejection of metastases arising from intraocular tumors in mice.
Niederkorn JY; Knisely TL; Mayhew E
Invest Ophthalmol Vis Sci; 1986 Sep; 27(9):1355-61. PubMed ID: 3091527
[TBL] [Abstract][Full Text] [Related]
12. Infiltration and accumulation of precursor cytotoxic T-cells increase with time in progressively growing ocular tumors.
Ksander BR; Bando Y; Acevedo J; Streilein JW
Cancer Res; 1991 Jun; 51(12):3153-8. PubMed ID: 1904003
[TBL] [Abstract][Full Text] [Related]
13. Promotion of syngeneic intraocular tumor growth in mice by anterior chamber-associated immune deviation.
Niederkorn JY; Streilein JW; Kripke ML
J Natl Cancer Inst; 1983 Jul; 71(1):193-9. PubMed ID: 6575203
[TBL] [Abstract][Full Text] [Related]
14. Ocular immune privilege is circumvented by CD4+ T cells, leading to the rejection of intraocular tumors in an IFN-{gamma}-dependent manner.
Dace DS; Chen PW; Alizadeh H; Niederkorn JY
J Leukoc Biol; 2007 Feb; 81(2):421-9. PubMed ID: 17077163
[TBL] [Abstract][Full Text] [Related]
15. Analysis of antibody production induced by allogeneic tumor cells inoculated into the anterior chamber of the eye.
Niederkorn JY; Streilein JW
Transplantation; 1982 Jun; 33(6):573-7. PubMed ID: 6808721
[TBL] [Abstract][Full Text] [Related]
16. Reconsidering the immunologic privilege and lymphatic drainage of the anterior chamber of the eye.
Niederkorn JY; Lynch MG
Transplant Proc; 1989 Feb; 21(1 Pt 1):259-60. PubMed ID: 2495604
[No Abstract] [Full Text] [Related]
17. Immune privilege extended to allogeneic tumor cells in the vitreous cavity.
Jiang LQ; Streilein JW
Invest Ophthalmol Vis Sci; 1991 Jan; 32(1):224-8. PubMed ID: 1987103
[TBL] [Abstract][Full Text] [Related]
18. Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites.
Ksander BR; Streilein JW
J Immunol; 1990 Oct; 145(7):2057-63. PubMed ID: 1975822
[TBL] [Abstract][Full Text] [Related]
19. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
20. Immunogenetic basis for immunologic privilege in the anterior chamber of the eye.
Niederkorn JY; Shadduck JA; Streilein JW
Immunogenetics; 1981; 13(3):227-36. PubMed ID: 6792066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
